IMMUTEP ADR |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.66 EUR | +3.91% |
|
+3.10% | +25.47% |
| 10:57am | Immutep, Merck Collaborate on Trial for Lung Cancer Therapy | MT |
| 07:20am | Immutep, Merck Partner for Efti and Keytruda Combo in Lung Cancer Trial | MT |
Chart: Technical Analysis
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- IMM Stock
- YP1A Stock
- Charts Immutep ADR
